COMBIPHAR
Ananda Ambarsari is an experienced professional with a diverse background in business development, operations, and strategic growth across multiple industries. Currently serving in the Transformation Management Office at COMBIPHAR since June 2022, Ananda previously held roles at Nalagenetics, focusing on client engagement and operational development for new services, and at Sayurbox, where collaboration across departments facilitated growth initiatives. Prior experience includes a Senior Associate position at White Rook Advisory, where Ananda contributed to corporate strategy through research and stakeholder engagement. Furthermore, Ananda worked as a Business Analyst at Solidiance, conducting market analysis, and participated as an Indonesian Delegate for the Harvard Project for Asian and International Relations in 2018. Ananda’s academic background includes a degree in Bioentrepreneurship from the Indonesia International Institute for Life-Sciences.
This person is not in any teams
COMBIPHAR
1 followers
Combiphar was founded in 1971 as a pharmaceutical company. Today, Combiphar is transforming into a modern consumer healthcare company that produces and markets more than 200 prescription and over-the-counter quality and affordable products, among others, OBH Combi cough syrup, Insto eye-care solution, JointFit gel-based relief for joints, CombiKid vitamin supplements, Privé green-tea based feminine hygiene wash, and Hezandra hepatoprotector supplement. Equipped with the latest production technology and the most up-to-date professional operation standards, Combiphar’s manufacturing plant, which is located in Padalarang, West Java, has most recently obtained the Therapeutic Goods Administration (TGA) Certification, allowing selected products to be exported to Australia. Additionally, Combiphar also has its own Research & Development facility, focusing on the quality optimization of prescription drugs to ensure that they meet the requirements of Bioavailability and Bioequivalence, as well as in the field of Nanotechnology. Combiphar has recently been ranked 2nd among local pharmaceutical companies recognized as “Indonesia’s Most Reputable Healthcare Brands 2015” (Onbee Research/SWA, May 2015) in terms of brand equity, customer loyalty, and customer experience.